Mealey's (May 13, 2019, 1:38 PM EDT) -- WILMINGTON, Del. — In a May 9 decision a Delaware federal judge agreed with a patent defendant that a plaintiff’s claims of infringement under the doctrine of equivalents are barred by the disclosure-dedication doctrine (Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, No. 18-1953, D. Del., 2019 U.S. Dist. LEXIS 78146)....